NCT06624839View on ClinicalTrials.gov

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2028

Conditions
Human Papilloma VirusAnal DysplasiaHIV
Interventions
BIOLOGICAL

Human papillomavirus (HPV) vaccine, 9-valent

0.5 ml intramuscular injection

Trial Locations (2)

20002

NOT_YET_RECRUITING

RIIS Clinic at HIPS, Washington D.C.

21201

RECRUITING

RIIS Clinic at Baltimore Safe Haven, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER